GN Store Nord AS GNN
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- DKK 20.80
- Day Range
- DKK 20.93–20.93
- 52-Week Range
- DKK 20.59–78.82
- Bid/Ask
- DKK 0.00 / DKK 0.00
- Market Cap
- DKK 3.05 Bil
- Volume/Avg
- 0 / 4
Key Statistics
- Price/Earnings (Normalized)
- 18.25
- Price/Sales
- 1.23
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
GN Store Nord is a Danish company offering medical and audio solutions. The group consists of two businesses: audio (about 62% of sales) and hearing (38%). GN Hearing offers hearing aids, competing globally with Sonova, Demant, Starkey, and WS Audiology (previously Sivantos and Widex). GN Audio provides headsets and speakerphones to the enterprise market (contact centers and offices), as well as to the consumer market, and recently acquired SteelSeries in the gaming market. The company has positioned itself as one of the main players in the Unified Communication-enabled headsets market. The firm’s premium brands are Resound in hearing and Jabra in headsets.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 7,162
- Website
- https://www.gn.com
Competitors
Valuation
|
Metric
|
GNN
|
PHIA
|
DEMANT
|
|---|---|---|---|
Price/Earnings (Normalized) | 18.25 | 21.51 | 22.12 |
Price/Book Value | 2.22 | 2.20 | 6.13 |
Price/Sales | 1.23 | 1.52 | 2.59 |
Price/Cash Flow | 8.59 | 21.15 | 14.29 |
Price/Earnings
GNN
PHIA
DEMANT
Financial Strength
|
Metric
|
GNN
|
PHIA
|
DEMANT
|
|---|---|---|---|
Quick Ratio | 0.47 | 0.66 | 0.75 |
Current Ratio | 0.68 | 1.16 | 1.42 |
Interest Coverage | 4.20 | 0.15 | 6.32 |
Quick Ratio
GNN
PHIA
DEMANT
Profitability
|
Metric
|
GNN
|
PHIA
|
DEMANT
|
|---|---|---|---|
Return on Assets (Normalized) | 1.95% | 4.12% | 8.21% |
Return on Equity (Normalized) | 6.04% | 10.11% | 27.51% |
Return on Invested Capital (Normalized) | 3.45% | 6.98% | 12.10% |
Return on Assets
GNN
PHIA
DEMANT
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Gcvwlxwkq | Stbyvl | $196.1 Bil | |||
| Stryker Corp
SYK
| Clnkbxqcv | Xbm | $137.7 Bil | |||
| Boston Scientific Corp
BSX
| Rcpnrgrj | Wxkkk | $122.3 Bil | |||
| Medtronic PLC
MDT
| Tfsqxcw | Tzmmtp | $114.7 Bil | |||
| Edwards Lifesciences Corp
EW
| Xdtklfmxz | Bhycnpx | $39.6 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Cnrv | Sjwg | $29.1 Bil | |||
| DexCom Inc
DXCM
| Flfsvgkxl | Hyrqj | $27.1 Bil | |||
| Steris PLC
STE
| Rfdvgzqmr | Wktsln | $23.3 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Hvccqqvx | Rrfx | $21.9 Bil | |||
| Insulet Corp
PODD
| Xwppbnwt | Qysjk | $16.5 Bil |
United States